{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:behestan-darou-company",
    "identifier": "hg:company:behestan-darou-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Behestan Darou Company",
    "slug": "behestan-darou-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/behestan-darou-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/behestan-darou-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/behestan-darou-company",
    "summary": "",
    "machine_summary": "Behestan Darou Company Behestan Darou Company is a Tehran-based private pharmaceutical importer and distributor active in specialty and regulated healthcare products. In the Hormuz Group company graph, it matters because access to imported medicines, biological drugs, hospital therapies, and rare-disease treatments depends on licensing, payment channels, regulatory approval, logistics, and cold-chain capacity. The company is best understood as a healthcare-access and import-dependence node rather than a manufacturing platform. Behestan Darou is relevant for investors assessing Iran's pharmaceutical import dependence, specialty-drug access, hospital procurement, regulatory risk, payment constraints, and healthcare supply shortages. It can support analysis of how foreign-origin medicines enter Iran, where supply-chain bottlenecks appear, and how compliance or money-transfer limits affect healthcare availability. Due diligence should verify current distribution licenses, supplier relationships, product registrations, cold-chain capability, ownership, sanctions exposure, receivables from public or private buyers, and continuity of import channels. Behestan Darou Company imports, registers, markets, and distributes pharmaceutical and healthcare products, with emphasis on specialty medicines, biological products, hospital drugs, rare-disease treatments, oncology-related therapies, and regulated healthcare supply. Its role is linked to import licensing, medical distribution, cold-chain handling, hospital procurement, and access to foreign-origin medicines. province: Tehran industry: Healthcare & Pharma, Medical Devices, Pharmaceuticals market: Consumer Demand, Healthcare, Imports, Supply Chains challenges: Compliance, Import Dependence, Money Transfer, Supply Shortage company_type: Distributor, Importer, Private Company city: Tehran",
    "published_at": "2026-06-28T20:21:35+00:00",
    "modified_at": "2026-06-28T20:21:35+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 122,
                "name": "Medical Devices",
                "slug": "medical-devices",
                "url": "https://hormuz.group/industry/healthcare-pharma/medical-devices/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 57,
                "name": "Imports",
                "slug": "imports",
                "url": "https://hormuz.group/market/trade-transit/imports/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 160,
                "name": "Money Transfer",
                "slug": "money-transfer",
                "url": "https://hormuz.group/challenges/financial-barriers/money-transfer/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            }
        ],
        "company_type": [
            {
                "id": 302,
                "name": "Distributor",
                "slug": "distributor",
                "url": "https://hormuz.group/company-type/distributor/"
            },
            {
                "id": 301,
                "name": "Importer",
                "slug": "importer",
                "url": "https://hormuz.group/company-type/importer/"
            },
            {
                "id": 307,
                "name": "Private Company",
                "slug": "private-company",
                "url": "https://hormuz.group/company-type/private-company/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Medical Devices, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Imports, Supply Chains",
        "challenges": "Compliance, Import Dependence, Money Transfer, Supply Shortage",
        "company_type": "Distributor, Importer, Private Company",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Behestan Darou Company",
        "website": "https://www.behestandarou.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "listing_status": "private",
        "products_services": "Behestan Darou Company imports, registers, markets, and distributes pharmaceutical and healthcare products, with emphasis on specialty medicines, biological products, hospital drugs, rare-disease treatments, oncology-related therapies, and regulated healthcare supply. Its role is linked to import licensing, medical distribution, cold-chain handling, hospital procurement, and access to foreign-origin medicines.",
        "export_relevance": "none",
        "short_profile": "Behestan Darou Company is a Tehran-based private pharmaceutical importer and distributor active in specialty and regulated healthcare products. In the Hormuz Group company graph, it matters because access to imported medicines, biological drugs, hospital therapies, and rare-disease treatments depends on licensing, payment channels, regulatory approval, logistics, and cold-chain capacity. The company is best understood as a healthcare-access and import-dependence node rather than a manufacturing platform.",
        "investment_relevance": "Behestan Darou is relevant for investors assessing Iran's pharmaceutical import dependence, specialty-drug access, hospital procurement, regulatory risk, payment constraints, and healthcare supply shortages. It can support analysis of how foreign-origin medicines enter Iran, where supply-chain bottlenecks appear, and how compliance or money-transfer limits affect healthcare availability. Due diligence should verify current distribution licenses, supplier relationships, product registrations, cold-chain capability, ownership, sanctions exposure, receivables from public or private buyers, and continuity of import channels."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Behestan Darou Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "export_relevance": "none",
        "verification_status": "basic",
        "data_confidence": "medium",
        "listing_status": "private",
        "last_updated": "28/06/2026",
        "website": "https://www.behestandarou.com",
        "products_services": "Behestan Darou Company imports, registers, markets, and distributes pharmaceutical and healthcare products, with emphasis on specialty medicines, biological products, hospital drugs, rare-disease treatments, oncology-related therapies, and regulated healthcare supply. Its role is linked to import licensing, medical distribution, cold-chain handling, hospital procurement, and access to foreign-origin medicines.",
        "short_profile": "Behestan Darou Company is a Tehran-based private pharmaceutical importer and distributor active in specialty and regulated healthcare products. In the Hormuz Group company graph, it matters because access to imported medicines, biological drugs, hospital therapies, and rare-disease treatments depends on licensing, payment channels, regulatory approval, logistics, and cold-chain capacity. The company is best understood as a healthcare-access and import-dependence node rather than a manufacturing platform.",
        "investment_relevance": "Behestan Darou is relevant for investors assessing Iran's pharmaceutical import dependence, specialty-drug access, hospital procurement, regulatory risk, payment constraints, and healthcare supply shortages. It can support analysis of how foreign-origin medicines enter Iran, where supply-chain bottlenecks appear, and how compliance or money-transfer limits affect healthcare availability. Due diligence should verify current distribution licenses, supplier relationships, product registrations, cold-chain capability, ownership, sanctions exposure, receivables from public or private buyers, and continuity of import channels.",
        "source_note": "Based on public company, healthcare-sector, pharmaceutical-import, market, and registry-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 22
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 7
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 413
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 509
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 628
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 207
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, healthcare-sector, pharmaceutical-import, market, and registry-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "medium",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "medium",
        "last_updated": "28/06/2026"
    }
}